Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natasha Honoré"'
Autor:
Aurélie Louvet, Natasha Honoré, Anne-France Dekairelle, Cédric Van Marcke, Jean-Charles Goeminne
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
A non-small-cell-lung-cancer patient with cerebral metastasis presenting an atypical exon 20 mutation in the EGFR gene had a long-lasting tumor cotrol on mulimodal treatment with osimertinib and stereotaxic radiotherapy on oligoprogressing lesions. M
Externí odkaz:
https://doaj.org/article/5236501bea2f4f72bf37b7e0977d7438
Publikováno v:
Critical Issues in Head and Neck Oncology ISBN: 9783031231742
Pembrolizumab and nivolumab, two monoclonal antibodies (mAbs) targeting programmed cell death protein-1 (PD-1), improve the overall survival of patients with inoperable recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e97e48216b3865292be3ff1b54853e67
https://doi.org/10.1007/978-3-031-23175-9_11
https://doi.org/10.1007/978-3-031-23175-9_11
Autor:
Sebastien Sauvage, Natasha Honoré, Guillaume Grisay, Emmanuel Seront, Valentin Van den Bossche, David Augusto, Gaspard Jadot, Bénédicte Petit, Jean-François Laes, Julien Pierrard
Publikováno v:
Targeted Oncology. 15:139-146
We describe in a patient with breast cancer the change in c-MET expression during everolimus treatment, opening a better understanding of the resistance to everolimus and a role for cabozantinib. The objective of this study was to evaluate c-MET as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3b21585cc6a278c11461a183179ef0
https://doi.org/10.1007/s11523-020-00704-2
https://doi.org/10.1007/s11523-020-00704-2